2026 healthcare conference: Signals for life sciences investors

Tern plc

The 2026 healthcare investment conference in San Francisco delivered a clear message to markets. Healthcare companies are being judged less on ambition and more on execution. Management teams across biotechnology, pharmaceuticals, medical technology and health services presented strategies that prioritised operational clarity.

Artificial intelligence remained central to strategic discussions, but the focus has matured. Rather than broad claims about transformation, companies highlighted specific use cases with defined economic impact. The investment relevance lies in whether AI reduces development timelines, lowers trial costs, sharpens targeting or strengthens commercial productivity. Businesses that demonstrated integration of AI into core operations appeared better positioned to defend valuations and attract long term capital.

Mergers and acquisitions were also firmly back on the agenda. However, activity is becoming more selective. Larger organisations are targeting assets that address clear pipeline gaps or add differentiated capabilities.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines uses AI to turn medical congress discussions into pharma insights

Talking Medicines uses AI to analyse healthcare professional conversations at medical congresses, turning discussions into structured insights that help...

Novo Nordisk deal puts focus on next generation of oral GLP-1 treatments

Novo Nordisk secures rights to Hengrui's investigational HRS-1596 in a potential $2.6bn deal, targeting the development of once-weekly oral...

Device Authority warns supermarket freezer cyberattack exposes connected device security risks

Device Authority warns that a cyberattack affecting around 700 French supermarkets exposes security weaknesses in connected industrial equipment and...

Breast cancer research highlights importance of patient intelligence in pharma

Talking Medicines highlights how AI-powered patient intelligence can help pharmaceutical companies understand breast cancer treatment experiences and identify unmet...

GLP-1 drugs linked to emerging research into mental health and addiction

Research into GLP-1 medicines is expanding beyond weight loss, with studies examining potential links to depression, cognitive function, alcohol...

Talking Medicines examines emerging links between GLP-1 drugs and mental health

Researchers are investigating the potential links between GLP-1 medicines and mental health, with early findings prompting further studies into...

Search